Intersteate Phlebotomy Service Inc Catonsville, MD - 21228

Intersteate Phlebotomy Service Inc is categorized under Health Services in Catonsville, MD and active since 2001.

Intersteate Phlebotomy Service Inc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.

If you are seeking more information, feel free to contact Lucile Sizer at the company’s single location by writing to 583 Frederick Road # 5b, Catonsville, Maryland MD 21228 or by phoning (410) 788-6246. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Intersteate Phlebotomy Service Inc
Contact Person: Lucile Sizer
Address: 583 Frederick Road # 5b, Catonsville, Maryland 21228
Phone Number: (410) 788-6246
Annual Revenue (USD): $100.000 to $499.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 621999
Share This Business:

Intersteate Phlebotomy Service Inc was started in 2001 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Lucile Sizer for inquiries that concern Intersteate Phlebotomy Service Inc by calling the company number (410) 788-6246, as your correspondence is most welcome. Additionally, the physical location of the single location of Intersteate Phlebotomy Service Inc can be found at the coordinates 39.272563,-76.728387 as well as the street address 583 Frederick Road # 5b in Catonsville, Maryland 21228.

For its online presence, you may visit Intersteate Phlebotomy Service Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.